<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H0ACD7458C8DA44349D24E7BCF624CE3C" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 5916 IH: Accurate Labeling of Menstrual Products Act of 2016</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2016-07-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">114th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 5916</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20160718">July 18, 2016</action-date><action-desc><sponsor name-id="M001188">Ms. Meng</sponsor> (for herself and <cosponsor name-id="M000087">Mrs. Carolyn B. Maloney of New York</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to require the label on certain menstrual
			 products to include an ingredient list, and for other purposes.</official-title></form>
	<legis-body id="HA2FF028B9D40409DBC534FEE6D40DC93" style="OLC">
 <section id="H511DEF21C9B54E98B30DDE0AEBC62329" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Accurate Labeling of Menstrual Products Act of 2016</short-title></quote>.</text> </section><section id="HAA989742C20A4F13A16CF79D07B743A3" section-type="subsequent-section"><enum>2.</enum><header>Labeling requirement for menstrual products</header> <subsection id="HC2864AA441F549CA89A41D3C6855704A"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 502 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/352">21 U.S.C. 352</external-xref>) is amended by inserting at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H50E7A9A6EDC04735B92969B35C5DDF2E" style="OLC">
 <subsection id="HD7964C6CD4DD4F528D18A5FA1D37949E"><enum>(dd)</enum><text display-inline="yes-display-inline">If it is an obstetrical and gynecological device described in section 884.5400, 884.5425, 884.5435, 884.5460, 884.5470, or 884.5900 of title 21, Code of Federal Regulations (or any successor regulation), unless it bears a label listing the name of each ingredient or component of the device in order of the most predominant ingredient or component to the least predominant ingredient or component.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
 </subsection><subsection id="H53DD367F922847A1A9ACA7EB31F6F1B9"><enum>(b)</enum><header>Date of application</header><text>The amendment made by subsection (a) applies only with respect to a device manufactured more than one year after the date of the enactment of this Act.</text>
			</subsection></section></legis-body></bill>


